Serum and cerebrospinal fluid morphine pharmacokinetics after single doses of intravenous and intramuscular morphine after hip replacement surgery
- PMID: 17619868
- DOI: 10.1007/s00228-007-0329-x
Serum and cerebrospinal fluid morphine pharmacokinetics after single doses of intravenous and intramuscular morphine after hip replacement surgery
Abstract
Aim: To compare the time course of morphine and metabolite concentrations in serum and cerebrospinal fluid (CSF) after intravenous and intramuscular administration after surgery.
Methods: This was a randomized double-blind, double-dummy study in patients who had undergone hip replacement surgery. Morphine (M, 10 mg) was administered intravenously (IV) or intramuscularly (IM). Arterial blood and CSF samples (from a spinal catheter) were drawn simultaneously at 10, 30, 60, and 120 min after administration. Morphine and metabolites [morphine-3-glucuronide (M-3-G), morphine-6-glucuronide (M-6-G), and normorphine (NM)] were determined by a validated liquid chromatography-tandem mass spectrometry method.
Results: Thirty-eight patients were included: 13 men and 25 women, 20 in the IV, 18 in the IM group. Serum concentrations of M after 10 min were consistently higher after IM than IV, concentrations of M-3-G and M-6-G after IM surpassed those of IV after 45 min. NM was not found. None of the metabolites was found in CSF. CSF morphine concentrations and CSF/serum concentration ratios were consistently higher after IV compared to IM. The mean AUC(CSF)/AUC(serum) (0-120 min) concentration ratios were 0.18 and 0.09 after IV and IM, respectively.
Conclusions: The uptake of morphine to the CSF was consistently higher after IV administration than after IM already after 10 min. The higher CSF concentration may be caused by an initially higher morphine blood/CSF gradient following IV morphine injection. The pharmacokinetic findings are compatible with a more rapid and extensive initial effect of IV morphine compared with IM.
Similar articles
-
A controlled comparison between single doses of intravenous and intramuscular morphine with respect to analgesic effects and patient safety.Acta Anaesthesiol Scand. 2008 Aug;52(7):920-5. doi: 10.1111/j.1399-6576.2008.01608.x. Acta Anaesthesiol Scand. 2008. PMID: 18702754 Clinical Trial.
-
Comparative measurement of spinal CSF microdialysate concentrations and concomitant antinociception of morphine and morphine-6beta-glucuronide in rats.Life Sci. 2007 Mar 13;80(14):1319-26. doi: 10.1016/j.lfs.2006.12.018. Epub 2007 Jan 11. Life Sci. 2007. PMID: 17258777
-
Postoperative analgesia with intramuscular morphine at fixed rate versus epidural morphine or sufentanil and bupivacaine in patients undergoing major abdominal surgery.Anesth Analg. 1998 Dec;87(6):1346-53. Anesth Analg. 1998. PMID: 9842825 Clinical Trial.
-
Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide.Br J Anaesth. 2014 Dec;113(6):935-44. doi: 10.1093/bja/aeu186. Epub 2014 Jul 1. Br J Anaesth. 2014. PMID: 24985077 Review.
-
Clinical pharmacokinetics of morphine.Ther Drug Monit. 1991 Jan;13(1):1-23. doi: 10.1097/00007691-199101000-00001. Ther Drug Monit. 1991. PMID: 2057987 Review.
Cited by
-
Use and safety of peripherally inserted central catheters and midline catheters in palliative care cancer patients: a retrospective review.Support Care Cancer. 2023 Sep 19;31(10):580. doi: 10.1007/s00520-023-08045-2. Support Care Cancer. 2023. PMID: 37725150 Free PMC article.
-
MRGPRX2 and Adverse Drug Reactions.Front Immunol. 2021 Aug 6;12:676354. doi: 10.3389/fimmu.2021.676354. eCollection 2021. Front Immunol. 2021. PMID: 34421893 Free PMC article. Review.
-
Use of peripherally inserted central venous catheters and midline catheters for palliative care in patients with cancer: a systematic review.Support Care Cancer. 2024 Jun 26;32(7):464. doi: 10.1007/s00520-024-08664-3. Support Care Cancer. 2024. PMID: 38926160 Free PMC article.
-
The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection.Patient Prefer Adherence. 2015 Jul 2;9:923-42. doi: 10.2147/PPA.S87271. eCollection 2015. Patient Prefer Adherence. 2015. PMID: 26170642 Free PMC article. Review.
-
Pharmacokinetics and dosage adjustment in patients with renal dysfunction.Eur J Clin Pharmacol. 2009 Aug;65(8):757-73. doi: 10.1007/s00228-009-0678-8. Epub 2009 Jun 20. Eur J Clin Pharmacol. 2009. PMID: 19543887 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical